The goal of the project is to establish a high-throughput screening platform that can be used to identify small molecules that improve the muscle cell membrane fragility that is characteristic of Duchenne muscular dystrophy patients. To do this, Ms. Ainoa Tejedera Villafranca will be hosted by the Gilbert Lab in Toronto to (a) be trained […]
Read More